CIK 0001574094 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271448452
- Phone
- 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-01 | RYAN UNA S Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2023-10-01 | Marton Laurence Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2023-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2023-10-01 | Diamond David Director | Grant or award · Stock Options (right to buy) | +25,099 | 25,099 | ||
| 2023-04-25 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +43,026 | 43,026 | ||
| 2023-03-15 | Agah Ramtin Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2023-03-15 | Bagai Shaun CEO | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2023-03-15 | Nelms Angela Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +32,500 | 32,500 | ||
| 2022-11-03 | Marton Laurence Director | Option exercise | +25,438 | $1.70 | $43K | 25,438 |
| 2022-11-03 | Marton Laurence Director | Option exercise · Stock Option (right to buy) | −25,438 | 0 | ||
| 2022-10-01 | RYAN UNA S Director | Grant or award · Stock Option (right to buy) | +25,099 | 25,099 | ||
| 2022-10-01 | Marton Laurence Director | Grant or award · Stock Option (right to buy) | +25,099 | 25,099 | ||
| 2022-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Option (right to buy) | +25,099 | 25,099 | ||
| 2022-10-01 | Diamond David Director | Grant or award · Stock Option (right to buy) | +25,099 | 25,099 | ||
| 2022-09-19 | Nelms Angela Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +274,230 | 274,230 | ||
| 2022-06-07 | Agah Ramtin Chief Medical Officer | Purchase | +5,182 | $1.93 | $10K | 6,477 |
| 2022-05-19 | Bagai Shaun Chief Executive Officer | Purchase | +5,500 | $2.05 | $11K | 251,557 |
| 2022-04-22 | RYAN UNA S Director | Other acquisition | +26,838 | $0.93 | $25K | 80,959 |
| 2022-04-22 | RYAN UNA S Director | Other acquisition | +16,206 | $1.62 | $26K | 97,165 |
| 2022-03-16 | Agah Ramtin Chief Medical Officer | Gift | −975,000 | 1,295 |
Page 5 of 6 · 120 trades